LONDON, UK I June 02, 2025 I GSK plc (LSE/NYSE: GSK) today announced the US Food and Drug Administration (FDA) has accepted for review the NDA for ...

London stocks nudged just a touch higher in early trade on Thursday as investors eyed an expected rate cut by the European ...

(Alliance News) - Stocks were called higher in the UK on Wednesday, as industry spokespeople cautiously welcome Donald Trump's decision to keep tariffs at 25% on British steel and aluminium for now.

The FTSE 100 index closed up 12.76 points, 0.2%, at 8,787.02. The FTSE 250 ended down 11.19 points, 0.1%, at 21,017.78, and ...

Britain's blue-chip stocks index ended slightly higher on Tuesday, as defence stocks climbed after the government pledged ...

The FTSE 100 index closed up 12.76 points, 0.2%, at 8,787.02. The FTSE 250 ended down 11.19 points, 0.1%, at 21,017.78, and the AIM All-Share closed up 5.38 points, 0.7%, at 753.51.

U.K. stocks rose Tuesday, as the FTSE 100 Index UKX +0.15% closed up 0.15% at 8,787.02. Of the FTSE 100 constituents, multiutilities company Centrica PLC CNA +4.36% saw the largest increase Tuesday, ...

The 12-year-old company had been collaborating with British pharmaceutical giant GlaxoSmithKline on an immuno-oncology drug ...

Mumbai: GlaxoSmithKline Pharmaceuticals Limited has announced the appointment of Chinmay Sharma, Executive Vice President - ...

London: GSK plc has announced the New Drug Application (NDA) for linerixibat, an investigational targeted inhibitor of the ...

US FDA accepts for review GSK’s NDA for linerixibat to treat cholestatic pruritus in patients with PBC: London, UK Tuesday, June 3, 2025, 11:00 Hrs [IST] GSK plc announced the U ...

Stephen Hemsley returned to the top job last month after the healthcare giant reported its first earnings miss since 2008.